DEBATE: Endovascular Treatments Should Be The First Option For Most Patients With CLTI – Today And In The Future

4-Year Results Of The IN.PACT SFA RCT Comparing The In.Pact Admiral DCB (Medtronic) vs. POBA In Fem-Pop Lesions: The Patency Benefits Persist And With Various Lesions In Different Patient Groups

Drug Eluting Devices Are The New Standard For Fem-Pop Endovascular Treatments For IC: The Timing Of Development Of Restenosis Is A Guide To Why Extended Drug Release Is Important With DESs: Which DES Has It

The Silk Road System For Transcervical Access With Reversal Of Flow To Perform CAS-TCAR: Results Of The ROADSTER Trial Demonstrate Safety And Efficacy Of The Enroute Version Of The System: Lessons Learned

A Better Approach To Treat Complex Type 2 Endoleaks After EVAR: Transfemoral Inside The Artery And Outside The Endograft: How To Do It